Tianjin Hengyu Medical Technology Co., Ltd.
PrivateLast Round
Strategic
Apr 21, 2026
Total Funding Raised
$42M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tianjin Hengyu Medical Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Tianjin. Its latest recorded funding round was a Strategic round in April 2026.
Tianjin Hengyu Medical Technology Co., Ltd. is a medical technology company that develops and manufactures cardiovascular imaging equipment and catheters, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT) systems.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tianjin Hengyu Medical Technology Co., Ltd. Comparables
Compare Tianjin Hengyu Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hengsheng Medical Group | 92% | |
| Insight Lifetech | 88% | |
| Shenzhen Vivolight Medical Device & Technology Co., Ltd. | 84% |
For institutional investors. Book with your work email.
Tianjin Hengyu Medical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 21, 2026 | ||||
| Series D Extension | Dec 8, 2025 | ||||
| Early Funding | Feb 20, 2025 | ||||
| Early Funding | Mar 22, 2024 | ||||
| Series D | Nov 1, 2023 | ||||
Early Funding | Jul 18, 2023 |
For institutional investors. Book with your work email.
Tianjin Hengyu Medical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CCIC Capital | Strategic |
| YuanBio Venture Capital | Early Funding |
| Beiyang Haitang Venture Capital Fund | Early Funding, Series D |
| Tasly Capital | Series C Extension, Early Funding, Series C |
| Wuxi Venture Capital Group | Strategic |
| Huatai Zijin Investment | Early Funding, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Raised $14M led by CCIC Capital and Wuxi Venture Capital Group.
- Dec 8, 2025
$14.2M raised in Series D Extension round.
For institutional investors. Book with your work email.
Tianjin Hengyu Medical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tianjin Hengyu Medical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Tianjin Hengyu Medical Technology Co., Ltd. a public or private company?
Tianjin Hengyu Medical Technology Co., Ltd. is a private company.
What is the current stock price of Tianjin Hengyu Medical Technology Co., Ltd.?
Tianjin Hengyu Medical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Tianjin Hengyu Medical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tianjin Hengyu Medical Technology Co., Ltd. worth (valuation)?
Valuation information for Tianjin Hengyu Medical Technology Co., Ltd. is not publicly available.
Can I buy Tianjin Hengyu Medical Technology Co., Ltd. stock?
Tianjin Hengyu Medical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tianjin Hengyu Medical Technology Co., Ltd.'s last funding round?
Tianjin Hengyu Medical Technology Co., Ltd.'s most recent funding round was Strategic on April 21, 2026.
Who are the main investors in Tianjin Hengyu Medical Technology Co., Ltd.?
Key investors in Tianjin Hengyu Medical Technology Co., Ltd. include CCIC Capital, Tasly Capital, Wuxi Venture Capital Group, Huatai Zijin Investment.
Will Tianjin Hengyu Medical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Tianjin Hengyu Medical Technology Co., Ltd..
How can I track Tianjin Hengyu Medical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Tianjin Hengyu Medical Technology Co., Ltd.'s shares on secondary markets.